引用次数
引用: 63,129
H-指数: 101
I10-指数 : 366
出版物: 915
Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study
S. Vatrano , L. Righi , T. Vavalá , I. Rapa
Targeted Oncology 11 ( 2) 157 -166
5
2016
Accuracy of CT-guided transthoracic needle biopsy of lung lesions: Results of 612 consecutive procedures
U. Ricardi , A. M. Priola , S. M. Priola , S. Novello
Journal of Clinical Oncology 25 18022 -18022
2007
MDM2 309 and TP53 Arg72Pro single nucleotide polymorphisms (SNPs) and clinical outcome in advanced lung cancer patients
S. Novello , G. Mandrile , D. F. Giachino , P. Ghio
Journal of Clinical Oncology 25 7636 -7636
2007
Clinical impact of ERCC1 and TOPOIIα gene expression in small-cell lung cancer patients treated with platinum/etoposide
G. Selvaggi , P. Ceppi , M. Longo , M. Giaj Levra
Journal of Clinical Oncology 25 2526 -2526
2007
Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome
F. Porpiglia , C. Fiori , F. C. Daffara , B. Zaggia
Journal of Endocrinological Investigation 39 ( 4) 465 -471
5
2016
Novel anti-angiogenic therapeutic strategies in colorectal cancer.
M. Tampellini , C. Sonetto , G. V. Scagliotti
Expert Opinion on Investigational Drugs 25 ( 5) 507 -520
69
2016
The place of targeted therapies in the management of non-small cell bronchial carcinoma. Target therapies in lung cancer management.
G.-V. Scagliotti , G. Selvaggi
Revue Des Maladies Respiratoires 23 ( 5) 137 -147
3
2006
Prognostic significance of osteopontin expression in malignant pleural mesothelioma
S Cappia , M Volante , P Ceppi , M. Papotti
Virchows Archiv 431 -431
2007
Predictive value of thymidylate synthase in epithelial and biphasic malignant pleural mesothelioma treated with pemetrexed
P Ceppi , E Bacillo , L Righi , G Selvaggi
Journal of Thoracic Oncology 4 346 -347
2009
ALTERED MRNAS EXPRESSION OF GENES INVOLVED IN CELLULAR IRON HOMEOSTASIS IN LUNG NON SMALL CELLS CARCINOMA
T Vavala , S Saviozzi , M Papotti , E Bracco
Journal of Thoracic Oncology 7 ( 7)
2012
MALATTIE DELL'APPARATO RESPIRATORIO. PNEUMOLOGIA E CHIRURGIA TORACICA
Francesco Sollitto , C Bucca , Maria Pia Foschino Barbaro , E Ruffini
EDIZIONI MINERVA MEDICA 1 -500
1
2015
Angiogenesis in stage in Non-Small-Cell Lung cancer (NSCLC) expression of Human protesa - activated receptors (PARS)
S Cappia , P Borasio , M Papotti , P Lausi
Annals of Oncology
2004
Large trials show survival advantage of adjuvant chemotherapy in NSCLC, but some data can be misleading
Gv Scagliotti
KETSUEKI SHUYOKA = HEMATOLOGY & ONCOLOGY 7 -9
2004
International Association for the Study of Lung Cancer (IASLC) Study of the Impact of COVID-19 on International Lung Cancer Clinical Trials
Mp Smeltzer , Gv Scagliotti , Ha Wakalee , T Mitsudomi
JOURNAL OF THORACIC ONCOLOGY /// -///
2022
PALLIATIVE CARE PATIENTS HAD A CIRCADIAN RHYTHMICITY IN THEIR BREAKTHROUGH PAIN (BTP) EPISODES
S Campagna , R Sperlinga , A Milo , A Saini
TUMORI 104 ( 4S) 150 -150
2018
Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy.
M. Onisto , M. Micela , C. Caenazzo , S. Garbisa
Cancer Research 52 ( 16) 4548 -4549
123
1992
Efficacy of Erlotinib in patients (PTS) with advanced non-small-cell lung cancer (NSCLC) relative to clinical charesteristics : subset analyses from the trust study
R. Pirker , G. Scagliotti , A. Franke , Léon Bosquee
American Journal of Clinical Oncology 26 ( 20)
2008
444PD Patient-reported outcomes (PROs) in ASCEND-5: A randomized, phase 3 study of ceritinib vs chemotherapy (CT) in patients (pts) with advanced anaplastic lymphoma kinase rearranged (ALK +) NSCLC previously treated with CT and crizotinib (CRZ)
A. Bearz , S. Deudon , S. Novello , A.T. Shaw
Annals of Oncology 27
1
2016
Standard versus alternating non-cross resistant chemotherapy in extensive disease small cell lung cancer: an EORTC study
J.Th.W. Burghouts , Desmond Curran , A. Kirkpatrick , T.A.W. Splinter
Elsevier Science Ltd.
1996
P01.21 ANSELMA: Antiangiogenic Second Line Lung Cancer Meta-Analysis on Individual Patient Data in Non-Small Cell Lung Cancer, Again Relevant in ICI Era
J Remon , B Lacas , R Herbst , M Reck
Journal of Thoracic Oncology 16 ( 3)
2021